2016 biomedical industry Collaborative Innovation Summit

Home page: Conference background human vaccine antibody drug project docking registration, contact us Brief introduction of the meeting a bout the conference summit has a biomedical industry development and investment and financing forum hosted by the Investment Promotion Bureau of the Ministry of Commerce, which takes "innovation driven, win-win cooperation" as the theme and deeply interprets the latest national industrial policies The summit also set up two sub forums on development and cooperation of antibody drugs & high-end human vaccines, aiming at the impact of the latest market trends and policy changes Visit the official website agenda August 25, 2016 (Thursday) 2016 Keynote speaker of biomedical industry development and investment and Financing Forum Unit 09:00-09:10 leader's speech: leader of the Ministry of Commerce Zhang Yuzhong deputy director of Investment Promotion Bureau of Ministry of Commerce 09:10-09:20 Leader's speech: Zhang Fabao, leader of Biovalley, chairman of Shanghai mace Pharmaceutical Technology Co., Ltd 09:20-09:50 research and judgment on the direction of pharmaceutical investment under the new policy environment Development trend of drug regulatory policies during the 13th Five Year Plan period of 09:50-10:20, deputy director of South Institute of pharmaceutical economics, State Food and Drug Administration Gao Huijun, deputy director of science and Technology Information Research Institute of Shanghai food and Drug Administration 10:20-10:40 Tea break 10:40-11:10 strategy and cooperation of multinational pharmaceutical companies in China Guan Zhiqiang, vice president of MSD China 11:10-11:40 TBD of Chinese pharmaceutical enterprises Zhao Nanding, director of cooperative innovation of Novartis (China) biomedical research Co., Ltd 11: 40-12:10 round table discussion: generic drug consistency evaluation triggers great changes in the industry: how do pharmaceutical companies think and respond? Explore market opportunities of health service industry and health care industry Wang Haibin, vice president of Zhejiang Haizheng Pharmaceutical Co., Ltd., Tian Wenzhi, Yi mingong, CEO of biomedical technology (Shanghai) Co., Ltd., Zhao Nanding Zhao Yining, director of cooperative innovation, Novartis (China) biomedical research Co., Ltd other guests of Venture Capital Partners of Asia Fund 12:10-14:00 Lunch break high end human vaccine industry development forum 14:00-14:30 Research and development of hypertension vaccine 14: 30-15:00 to develop a new vaccine adjuvant, or a new adjuvant for old drugs? Wang Bin professor of Fudan University 15:00-15:30 Jin Xia researcher of Shanghai Pasteur Institute 15:30-16:00 Chen Wen, researcher of cancer hospital, Chinese Academy of Medical Sciences 16: 00-16:20 tea break 16:20-16:50 Current situation of new vaccine R & D competition in the 21st century CEO of Shanghai Zerun Biotechnology Co., Ltd 16: Development of 50-17:20 pneumonia protein vaccine 17: 20-17:50 noantigen: the key to successful immunity Wang Jianxin General manager of Jiangsu Jian'an Biotechnology Co., Ltd Friday, August 26, 2016 Keynote speaker of antibody drug development and Cooperation Forum Unit 09:00-09:40 research and development of preparation of macromolecular protein drugs Han Jun director of Shandong antibody pharmaceutical Collaborative Innovation Center 09:40-10:20